Aft, Forsyth & Company, Inc. Csl LTD Transaction History

Aft, Forsyth & Company, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 08, 2021	SELL	$101.72 - $114.56 $233,956 - $263,488	-2,300 Closed	0 $0
Q2 2021 Jul 15, 2021	SELL	$100.62 - $116.66 $407,511 - $472,473	-4,050 Reduced 63.78%	2,300 $245,000
Q1 2021 May 04, 2021	SELL	$95.11 - $111.11 $1,902 - $2,222	-20 Reduced 0.31%	6,350 $643,000
Q1 2020 May 11, 2020	BUY	$79.09 - $114.05 $503,803 - $726,498	6,370 New	6,370 $582,000

153K

Ticker CSLLY
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 964,432,000
Market Cap $84.7B
Description
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plas...

Get notified when there are updates to the investment portfolio of Aft, Forsyth & Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Aft, Forsyth & Company, Inc. with notifications on news.